Krensavage Asset Management buys $27.6 Million stake in Orthofix International NV (OFIX)

Orthofix International NV (OFIX) : Krensavage Asset Management scooped up 2,969 additional shares in Orthofix International NV during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 643,145 shares of Orthofix International NV which is valued at $27.6 Million.Orthofix International NV makes up approximately 10.11% of Krensavage Asset Management’s portfolio.

Other Hedge Funds, Including , Chicago Equity Partners boosted its stake in OFIX in the latest quarter, The investment management firm added 430 additional shares and now holds a total of 40,620 shares of Orthofix International NV which is valued at $1.7 Million. Orthofix International NV makes up approx 0.05% of Chicago Equity Partners’s portfolio.Blackrock Institutional Trust Company N.a. reduced its stake in OFIX by selling 39,485 shares or 6.17% in the most recent quarter. The Hedge Fund company now holds 600,048 shares of OFIX which is valued at $25.8 Million. Princeton Alpha Management Lp sold out all of its stake in OFIX during the most recent quarter. The investment firm sold 8,719 shares of OFIX which is valued $374,743.Diam Ltd. boosted its stake in OFIX in the latest quarter, The investment management firm added 9,168 additional shares and now holds a total of 21,851 shares of Orthofix International NV which is valued at $939,156. Orthofix International NV makes up approx 0.01% of Diam Ltd.’s portfolio.Aperio Group reduced its stake in OFIX by selling 30 shares or 0.38% in the most recent quarter. The Hedge Fund company now holds 7,857 shares of OFIX which is valued at $343,822.

Orthofix International NV opened for trading at $44.42 and hit $44.79 on the upside on Wednesday, eventually ending the session at $44.26, with a gain of 0.07% or 0.03 points. The heightened volatility saw the trading volume jump to 1,27,133 shares. Company has a market cap of $807 M.

On the company’s financial health, Orthofix International NV reported $0.28 EPS for the quarter, beating the analyst consensus estimate by $ 0.11 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.17. The company had revenue of $98.70 million for the quarter, compared to analysts expectations of $93.10 million. The company’s revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.15 EPS.

Orthofix International N.V. (Orthofix) is a diversified global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians across the world. The company operates in four segments: BioStim Biologics Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts Trinity ELITE and Trinity Evolution among others. Its Extremity Fixation solutions include Fixator and Galaxy Fixation System among others. Its Spine Fixation solutions products include NewBridge Laminoplasty Fixation System and PILLAR PL & TL PEEK VBR System among others. It uses independent distributors as well as directly distributes its products in the United States Italy the United Kingdom Germany Switzerland Austria France Brazil Australia and Puerto Rico.

Leave a Reply

Orthofix International NV - Is it time to Sell?

Top Brokerage Firms are advising their investors on Orthofix International NV. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.